Home Innovation That Matters

Innovation That Matters

A Personal Journey in Creating Breakthrough Treatments for Disease

By Rich Soll, SVP of Research Service Division at WuXi AppTec (@richsollwx) “As you toil and try to solve some scientific problems along the way, you’re so focused on solving some of these problems that you really don’t necessarily appreciate the impact that your work...

Hua Medicine Breaking New Ground

This month's Innovation That Matters features an interview Dr. Li Chen, CEO of Hua Medicine.  Chen and his colleagues at Hua had much to celebrate in November as their novel Type II diabetes treatment entered clinical trials in China. This milestone marks the first case in China...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

The U.S. FDA Completed Pre-License Inspection (PLI) of WuXi Biologics CGMP...

We are pleased to announce that the U.S. Food and Drug Administration has completed the Pre-License Inspection (PLI) of WuXi Biologics cGMP manufacturing facilities...